We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Rebecca
Foster
Rebecca.Foster@stir.ac.uk
Dr
Rebecca
Foster
Rebecca.Foster@stir.ac.uk
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
This study will (1) create a novel Naloxone intervention for CNCP patients with POOR attending Community
Pharmacies (CPs) in NHS FifeÍľ (2) allow for online/postal delivery to reduce COVID-19 transmission riskÍľ (3) explore
the feasibility of recruiting CPs to deliver, and for CPs to recruit POOR patients and their family members to participateÍľ
(4) test the intervention in a sample of CPs in NHS Fife to assess the feasibility and acceptability of this approach.
Six CPs in areas of high CNCP opioid prescribing will be recruited. Patient recruitment will include those aged 18+
who are prescribed a strong opioid for CNCP who live with another person (who could administer naloxone in case of
OD), aiming for 20 patients per CP.
The lead pharmacist at each CP will identify suitable patients, provide them with verbal and written information on the
study and seek consent to pass on their name and phone number to the researchers. A researcher will contact the
patient, discuss the study, and seek their verbal consent to participate. Participating patients and 1+ person they live
with will receive the intervention (information on POOR, a supply of naloxone and training on how to use it).
Quantitative and qualitative data will be collected from pharmacists and patients, and analysed to assess the
feasibility and acceptability of the intervention and its delivery.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Education or Self-Management;
You can take part if:
You may not be able to take part if:
Patients: Currently receiving Opiate Substitution Therapy (prescribed methadone or buprenorphine tablets for substance use disorder) or Having ever been supplied with take-home naloxone.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Stirling and funded by SCOTTISH GOVERNMENT .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 47680
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
